DadFinStart your free week
DadFin › Stocks › Healthcare › POAS

Phaos Technology Holdings (Caym (POAS) stock score

Healthcare · Medical Devices · Singapore

$2.55 ▼ -22.49% today

53.3
Dad Score, out of 100
middling

Phaos Technology Holdings (Caym (POAS) is a Medical Devices company in the Healthcare sector, listed in Singapore. On DadFin's weekly run it scores 53.3 out of 100 on the Dad Score, a middling reading that places the business ahead of 53% of the 5,684 US and Canadian stocks DadFin fully scores. Inside Healthcare it ranks #378 of 956. Its strongest axes are price action, liquidity and macro; its weakest are quality and growth.

Scores from the run of Nov 15, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Average
Quality
Weak
Growth
Weak
Price action
Strong
Risk
Weak
Conviction
Average
Liquidity
Strong
Macro
Strong

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)—
P/E (forward)—
Dividend yield0.00%
Return on capital-113.2%
Operating margin-4787.1%
Revenue growth (YoY)-21.2%
FCF yield-16.1%
Net debt / EBITDA3.00×
Piotroski F-Score4 / 9
52-week change-94.2%
Market cap$53M
Next earnings—

What subscribers see on POAS

Start your free weekSubscriber? Open the full research →

Medical Devices peers

StockCompanyDad ScoreBandMarket cap
ABTAbbott Laboratories92.5strong$188.0B
MDTMedtronic plc100.0strong$131.6B
SYKStryker Corporation75.9good$117.9B
BSXBoston Scientific Corporation88.2strong$64.3B
EWEdwards Lifesciences Corporation90.6strong$61.6B
GEHCGE HealthCare Technologies Inc.98.1strong$37.5B
DXCMDexCom, Inc.75.4good$31.1B
PHGKoninklijke Philips N.V.90.7strong$29.7B

Prices from DadFin's live feed (refreshed about every 30 minutes in the session); scores from the weekly run of Nov 15, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.